All Articles

Cybersecurity firm Nord Security's latest impact report reveals a dual commitment to planetary health and digital rights, setting a new standard for responsible growth.

A new study reveals patients trust AI algorithms over doctor recommendations, forcing a high-stakes reckoning for medical practices and patient safety alike.

Litera's Foundation 365 isn't just another CRM. By embedding AI-powered client intelligence into Microsoft 365, it redefines how law firms build relationships.

With a potential $4 billion on the line, CytomX and Regeneron are building a new class of cancer therapies designed to act like autonomous agents in the body.

Top 20 firm Cherry Bekaert partners with Fieldguide for a massive agentic AI deployment, signaling a major industry shift from point tools to AI-native platforms.

A new free tool promises to arm security providers with an attacker's-eye view, but its real impact may be in reshaping the competitive landscape.

As Prime Medicine prepares for a key investor conference, its next-gen 'search and replace' gene editing technology faces a crucial test. Can it deliver on its promise?

With $50M in pre-sales and a Cabot golf course on the horizon, Revelstoke is redefining mountain living. But can it balance luxury growth with community character?

Amid global uncertainty, Deerpath Capital's $452M CLO reset offers a masterclass in financial strategy, prioritizing stability for long-term investors.

The AI boom is hitting a thermal wall. A new solution, born from electric supercar tech, promises to slash energy use and unlock unprecedented power.

Cemvita's breakthrough 75,000-liter scale-up turns biodiesel waste into renewable oil, paving the way for a new generation of Sustainable Aviation Fuel.

A new AI can detect Parkinson's progression where the current gold standard fails. In a stunning validation, the study was led by the very scientists who created the old method.

Crescent's largest-ever fund close highlights booming investor appetite for private credit and promises a major capital infusion for the U.S. lower middle market.

For decades, businesses have relied on robust IBM i systems. But what happens when they fail? A new AI-driven approach aims to prevent catastrophe, not just clean it up.

As autonomous AI enters healthcare, Datavant joins a key consortium to build the safety guardrails, ensuring patient trust and data integrity remain paramount.

New long-term data for UPLIZNA and TAVNEOS show sustained disease control and reduced steroid use, offering a tangible difference for rare disease patients.

With its massive Resulticks acquisition delayed again, London's Diginex tests investor faith, betting its future on an audacious ethics-meets-commerce vision.

Vanessa Fusco's win as top female roofer isn't just a personal victory. It signals a major shift in a male-dominated industry and a new model for social impact.

A new AI agent from AlphaSense promises to do more than just find data—it executes complex tasks. We look at the tech, trust, and future of work.

As its CEO takes the stage at a key defense summit, a look at how Palladyne AI's pivot from hardware to 'embodied AI' and vertical integration is creating a new model for a defense tech prime.